Dear Fellow Investor,
Investors should always be on the lookout for insights that could give them an edge in the stock market, and one potential source of such information is insider buying activity. When company insiders, such as executives or board members, buy shares of a company's stock, it can be seen as a vote of confidence in the company's prospects. Publicly available insider buying information can provide valuable clues about which stocks may be worth considering for investment.
Here are three stocks recently purchased by C-level insiders -
DiaMedica Therapeutics Inc. – SYM: DMAC
Recent Price: $4.25
Insider Action: 7 insiders buy $5.6 mil in shares
Description: DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke.
===
The #1 Gold and Silver Investment Strategy For 2023
Register for immediate access: The key to protecting your portfolio, securing your savings & growing your retirement wealth regardless of market conditions is just a click away!
Click Here For Immediate Access
===
VAALCO Energy, Inc. – SYM: EGY
Recent Price: $3.69
Get Insider Action Here >>>
Description: VAALCO Energy, Inc., an independent energy company, acquires, explores for, develops, and produces crude oil, natural gas, and natural gas liquids. The company holds Etame production sharing contract related to the Etame Marin block located offshore in the Republic of Gabon in West Africa. It also owns interests in an undeveloped block offshore Equatorial Guinea, West Africa. The company was incorporated in 1985 and is headquartered in Houston, Texas.
===
"Amazon Loophole" could hand you $28,544 in "royalty" payouts?!
Thanks to a little-known IRS loophole…regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the "Amazon secret royalty program." The best part is, there are NO age or income requirements. NO employment requirements.. and you NEVER have to shop or sell a single product on Amazon.
See how to collect the next payout before the strict cutoff deadline.
Watch this short video now.
===
Nutex Health Inc. – SYM: NUTX
Recent Price: $0.45
Get Insider Action Here >>>
Description: Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.
===
See An-E's stock price predictions of TSLA, NVDA, and AAPL
One of the world's top financial tech companies recently launched a breakthrough, new A.I. stock predictive system called An-E (pronounced Annie, short for Analytical Engine).
They tested it by tasking it with many thousands of stock predictions… and comparing its forecasts with what actually happened. And many of those predictions ended up being incredibly accurate, often times either spot on or only off a percentage or two.
Click here to learn more.
Tidak ada komentar:
Posting Komentar